LAT1-NRF2 axis controls sFlt-1/PlGF imbalance and oxidative stress in preeclampsia.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41087351.
- Also identified by DOI 10.1038/s41467-025-64160-0 and PMC identifier 12521483.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Preeclampsia (PE) is a complex disease with unclear etiology. It is the most dangerous human pregnancy disease, causing morbidity and mortality in thousands of women and newborns worldwide. The soluble fms-like tyrosine kinase-1 (sFlt-1) to placental growth factor (PlGF) ratio is currently the best and only predictive biomarker. The higher the ratio, the more likely the pregnant women will develop PE. The molecular mechanism underlying the increased sFlt-1/PlGF ratio is not known. Here, we show that amino acid transporter LAT1 (SLC7A5) and transcription factor NRF2 regulate this ratio via a previously unknown mechanism to produce sFlt-1 and PlGF in an anti-angiogenic ratio as observed in PE. In addition, we show that PE-associated oxidative stress, whose origin was unknown, is a secondary phenomenon caused by reduced NRF2 and LAT1 activity. The interdependence of the involved proteins, including also ATF4, Flt-1 and Akt, indicates that any disruption of the interaction would ultimately lead to a PE-like phenotype.
Medical subject headings
- Vascular Endothelial Growth Factor Receptor-1
- NF-E2-Related Factor 2
- Pre-Eclampsia
- Placenta Growth Factor
- Oxidative Stress
- Large Neutral Amino Acid-Transporter 1